Efficacy of antiplatelet drugs in the maintenance of aortocoronary vein bypass graft patency.
D000818:Animals; D001241:Aspirin / Q000494:pharmacology / Q000627:therapeutic use*; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism; D002986:Clinical Trials as Topic; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000517:prevention & control*; D016861:Cyclooxygenase Inhibitors; D004176:Dipyridamole / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D012501:Saphenous Vein / Q000637:transplantation; D013442:Sulfinpyrazone / Q000494:pharmacology / Q000627:therapeutic use*
D016861:Cyclooxygenase Inhibitors; D004176:Dipyridamole; D001241:Aspirin; D013442:Sulfinpyrazone